本頁面由Tiger Trade Technology Pte. Ltd.提供服務

再鼎醫藥

18.36
-0.4750-2.52%
成交量:17.04萬
成交額:313.57萬
市值:20.37億
市盈率:-11.45
高:18.70
開:18.59
低:18.27
收:18.83
52周最高:44.34
52周最低:15.96
股本:1.11億
流通股本:1.09億
量比:2.20
換手率:0.16%
股息:- -
股息率:- -
每股收益(TTM):-1.6026
每股收益(LYR):-1.6026
淨資產收益率:-22.56%
總資產收益率:-12.16%
市淨率:2.85
市盈率(LYR):-11.45

資料載入中...

2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/17

SEC問詢函

Form CORRESP - Correspondence
2024/02/09

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

重要事件披露

Form 8-K - Current report
2024/02/08

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/01

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]